UGT2A3 as a Biomarker for Ulcerative Colitis and Colon Cancer
Author Information
Author(s): Hao Chen
Primary Institution: The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
Hypothesis
Can UGT2A3 serve as a diagnostic marker for ulcerative colitis and colon cancer?
Conclusion
UGT2A3 is identified as a potential diagnostic marker for ulcerative colitis and colon cancer, showing significant downregulation in cancer tissues.
Supporting Evidence
- UGT2A3 showed high diagnostic accuracy with an AUC of 0.969.
- UGT2A3 was significantly downregulated in colon cancer tissues compared to normal controls.
- Correlation analysis indicated a link between UGT2A3 and the pathological classification of colon cancer.
Takeaway
Researchers found that a protein called UGT2A3 can help doctors tell if someone has ulcerative colitis or colon cancer.
Methodology
The study used gene expression data from public databases and machine learning methods to identify UGT2A3 as a diagnostic marker.
Potential Biases
Potential biases from using public datasets and limited healthy control samples.
Limitations
The sample size is small, and the study relies on data from public databases, which may introduce biases.
Participant Demographics
87 active ulcerative colitis patients and 19 normal patients were included.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 0.985–1.000
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website